Womens Health Diagnostics Market to Hit $21,502 Million by 2023

 According to a new report published by Allied Market Research, titled, Women's Health Diagnostics Market, by Type and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global women's health diagnostics market was valued at $13,133 million in 2016, and is projected to reach $21,501 million in 2023 at a CAGR of 7.0% from 2017 to 2023.

 

Gynecology is the main branch of medical science concerned with women's health problems. This includes the health related disorders, their screening and testing procedures. Women are highly prone to various cancers such as breast, cervical, and ovarian cancer. Other health issues include infertility, polycystic ovarian syndrome, menopause, depression, osteoporosis, and obesity.

 

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4521

 

Factors such as rise in prevalence of various chronic lifestyle disorders in women, rise in female geriatric population who are more prone to several disorders, increase in adoption of point of care diagnosis, high demand for imaging and diagnosing centers, and support from government in promoting awareness about women related disorders. However, factors such as expensive imaging procedures and lack of skilled professionals restrains the market growth. Conversely, huge untapped market potential in the emerging countries, such as South Africa and India, and development of novel and advanced imaging procedures such as miniature devices are expected to provide lucrative opportunities to the market players.

 

The diagnostic tests segment occupied the largest share in 2016, owing to the high usage, applicability, and availability of tests for detecting various disorders in women. Furthermore, the accessories and consumables segment is expected to grow at the highest CAGR of 7.8% from 2017 to 2023, and is anticipated to continue its dominance during the forecast period. The utilization rate of various women's health related diagnostics procedures for hospitals and clinics is high, however diagnostic and imaging centers segment is expected to grow at a CAGR of 7.8% during the forecast period. This is attributed to increase in incidence of various types of health-related disorders.

 

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4521

 

Key findings of the Women's Health Diagnostics Market:

• Diagnostic tests segment accounted for around 55.1% share of the global women's health diagnostics market in 2016
• Diagnostic devices segment is expected to grow at a CAGR of 6.5% from 2017 to 2023.
• Hospitals and clinics segment accounted for around 49.8% share of the global women's health diagnostics market in 2016
• North America accounted for around 33.7% share of the global women's health diagnostics market in 2016
• Asia-Pacific is expected to grow at the highest CAGR of 8.1% from 2017 to 2023

 

North America was the leading revenue contributor to the global women's health diagnostics market, accounting for nearly one-third of the global market. This is attributed to the presence of numerous screening tests for cancer detection and other diseases. Moreover, presence of key players and advanced diagnostics procedures such as 3D mammography. However, Asia-Pacific is expected to grow at the highest CAGR of 8.1% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness towards various women related disorders.

 

Womens Health Diagnostics Market Focus to Boost Revenue with Massive Growth

High demand for point-of-care diagnostics and growing awareness about the womens health related diagnostics drives the market growth. Focus of manufacturers on development of novel tests; such as hormone receptor tests and HPV test; to treat womens disorders would have a significant impact on the market growth throughout the forecast period.

Women's Health Diagnostics Market was valued at $13,133 million in 2016, and is projected to reach $21,501 million in 2023 at a CAGR of 7.0% from 2017 to 2023.

Gynecology is the main branch of medical science concerned with women's health problems. This includes the health-related disorders, their screening and testing procedures. Women are highly prone to various cancers such as breast, cervical, and ovarian cancer. Other health issues include infertility, polycystic ovarian syndrome, menopause, depression, osteoporosis, and obesity.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/4521

Factors such as rise in prevalence of various chronic lifestyle disorders in women, rise in female geriatric population who are more prone to several disorders, increase in adoption of point of care diagnosis, high demand for imaging and diagnosing centers, and support from government in promoting awareness about women related disorders. However, factors such as expensive imaging procedures and lack of skilled professionals restrains the market growth. Conversely, huge untapped market potential in the emerging countries, such as South Africa and India, and development of novel and advanced imaging procedures such as miniature devices are expected to provide lucrative opportunities to the market players.

The diagnostic tests segment occupied the largest share in 2016, owing to the high usage, applicability, and availability of tests for detecting various disorders in women. Furthermore, the accessories and consumables segment is expected to grow at the highest CAGR of 7.8% from 2017 to 2023, and is anticipated to continue its dominance during the forecast period. The utilization rate of various women's health related diagnostics procedures for hospitals and clinics is high, however diagnostic and imaging centers segment is expected to grow at a CAGR of 7.8% during the forecast period. This is attributed to increase in incidence of various types of health-related disorders.

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/4521

Key findings of the Women's Health Diagnostics Market:

• Diagnostic tests segment accounted for around 55.1% share of the global women's health diagnostics market in 2016
• Diagnostic devices segment is expected to grow at a CAGR of 6.5% from 2017 to 2023.
• Hospitals and clinics segment accounted for around 49.8% share of the global women's health diagnostics market in 2016
• North America accounted for around 33.7% share of the global women's health diagnostics market in 2016
• Asia-Pacific is expected to grow at the highest CAGR of 8.1% from 2017 to 2023

North America was the leading revenue contributor to the global women's health diagnostics market, accounting for nearly one-third of the global market. This is attributed to the presence of numerous screening tests for cancer detection and other diseases. Moreover, presence of key players and advanced diagnostics procedures such as 3D mammography. However, Asia-Pacific is expected to grow at the highest CAGR of 8.1% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness towards various women related disorders.

Womens Health Diagnostics Market to Expand at a Steady Growth Rate in the Coming Years

High demand for point-of-care diagnostics and growing awareness about the womens health related diagnostics drives the market growth. Focus of manufacturers on development of novel tests; such as hormone receptor tests and HPV test; to treat womens disorders would have a significant impact on the market growth throughout the forecast period.

Women's Health Diagnostics Market was valued at $13,133 million in 2016, and is projected to reach $21,501 million in 2023 at a CAGR of 7.0% from 2017 to 2023.

Gynecology is the main branch of medical science concerned with women's health problems. This includes the health-related disorders, their screening and testing procedures. Women are highly prone to various cancers such as breast, cervical, and ovarian cancer. Other health issues include infertility, polycystic ovarian syndrome, menopause, depression, osteoporosis, and obesity.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/4521

Factors such as rise in prevalence of various chronic lifestyle disorders in women, rise in female geriatric population who are more prone to several disorders, increase in adoption of point of care diagnosis, high demand for imaging and diagnosing centers, and support from government in promoting awareness about women related disorders. However, factors such as expensive imaging procedures and lack of skilled professionals restrains the market growth. Conversely, huge untapped market potential in the emerging countries, such as South Africa and India, and development of novel and advanced imaging procedures such as miniature devices are expected to provide lucrative opportunities to the market players.

The diagnostic tests segment occupied the largest share in 2016, owing to the high usage, applicability, and availability of tests for detecting various disorders in women. Furthermore, the accessories and consumables segment is expected to grow at the highest CAGR of 7.8% from 2017 to 2023, and is anticipated to continue its dominance during the forecast period. The utilization rate of various women's health related diagnostics procedures for hospitals and clinics is high, however diagnostic and imaging centers segment is expected to grow at a CAGR of 7.8% during the forecast period. This is attributed to increase in incidence of various types of health-related disorders.

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/4521

Key findings of the Women's Health Diagnostics Market:

• Diagnostic tests segment accounted for around 55.1% share of the global women's health diagnostics market in 2016
• Diagnostic devices segment is expected to grow at a CAGR of 6.5% from 2017 to 2023.
• Hospitals and clinics segment accounted for around 49.8% share of the global women's health diagnostics market in 2016
• North America accounted for around 33.7% share of the global women's health diagnostics market in 2016
• Asia-Pacific is expected to grow at the highest CAGR of 8.1% from 2017 to 2023

North America was the leading revenue contributor to the global women's health diagnostics market, accounting for nearly one-third of the global market. This is attributed to the presence of numerous screening tests for cancer detection and other diseases. Moreover, presence of key players and advanced diagnostics procedures such as 3D mammography. However, Asia-Pacific is expected to grow at the highest CAGR of 8.1% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness towards various women related disorders.

Womens Health Diagnostics Market is expected to see extensive worldwide growth

High demand for point-of-care diagnostics and growing awareness about the women’s health-related diagnostics drives the market growth. The focus of manufacturers on the development of novel tests; such as hormone receptor tests and HPV test; to treat women’s disorders would have a significant impact on the market growth throughout the forecast period.

The Global Women’s Health Diagnostics Market accounted for $13.1 Billion in 2016 and is expected to attain $21.5 Billion by 2023, growing at a CAGR of 7.0% during the forecast period, 2017-2023.North America was the leading revenue contributor to the global women’s health diagnostics market, accounting for nearly one-third of the global market. This is attributed to the presence of numerous screening tests for cancer detection and other diseases.

The surge in geriatric female population, increase in prevalence of various chronic and lifestyle disorders in women, rise in demand for point-of-care diagnostic testing, and high adoption of imaging procedures drive the growth of the global womens health diagnostics market. Additionally, miniaturization of ultrasound devices and untapped emerging economies provide lucrative opportunities for new market players. However, dearth of skilled professions and high cost of imaging and monitoring systems impede market growth.

Get Sample Copy of Report @ https://www.alliedmarketresearch.com/request-sample/4521

The report segments the global womens health diagnostics market by type, end user, and geography. Based on type, the market is fragmented into diagnostic devices, diagnostic tests, and accessories & consumables. The diagnostic tests segment contributed the highest revenue to the global market in 2016, owing to the high usage, applicability, and availability of tests for detecting various disorders in women. However, the accessories and consumables segment is poised to encounter the highest growth rate during the forecast period, a CAGR of 7.8%.

Based on end user, the report categorizes the market into hospitals & clinics, home care settings, and diagnostic & imaging centers. The hospitals & clinics segment dominated the global market in 2016 due to high utilization rate of various women’s health-related diagnostics procedures. However, the diagnostic & imaging centers segment is projected to grow at the fastest rate from 2017 to 2023, owing to increase in incidence of various types of health-related disorders. Regionally, North America accounted for more than one-third of the global market revenue in 2016, owing to the presence of numerous screening tests for cancer detection and other diseases. However, Asia-Pacific is expected to grow at the highest CAGR of 8.1% during the forecast period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness towards various women related disorders.

Top Key Players :

• Becton
• Dickinson and Company
• Carestream Health
• Hoffmann-La Roche AG
• GE Healthcare
• Hologic Inc.
• Koninklijke Philips N.V.
• Quest Diagnostics Inc.
• Cardinal Health
• Siemens AG.

They have adopted various strategies such as mergers & acquisitions, collaborations, partnerships, and others to gain a strong position in the industry.

Send Enquiry On Report @ https://www.alliedmarketresearch.com/purchase-enquiry/4521